<DOC>
	<DOCNO>NCT01534351</DOCNO>
	<brief_summary>This study design compare safety efficacy monotherapy finasteride combination therapy ( finasteride tamsulosin ) Asian men benign prostatic hyperplasia ( BPH ) least 50 year age old . The primary hypothesis concomitantly-dosed finasteride 5 mg tamsulosin 0.2 mg superior respect BPH symptom compare monotherapy finasteride 5 mg measure change baseline International Prostate Symptoms Score ( IPSS ) superior respect prostate volume reduction compare montherapy tamsulosin 0.2 mg measure percent change baseline prostate volume .</brief_summary>
	<brief_title>Comparison Finasteride Tamsulosin Treatment Benign Prostatic Hyperplasia ( BPH ) ( MK-0906A-149 AM2 )</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Possess clinical diagnosis BPH . Able read , understand , complete study questionnaire . History recurrent evidence condition , therapy , lab abnormality circumstance might confound result study , interfere participation full duration study . History malignancy â‰¤ 5 year prior sign inform consent , except adequately treat basal cell squamous cell skin cancer , include prostate cancer duration , evidence suspicion prostate cancer previous biopsy . History prostatic surgery invasive procedure treat BPH history bladder neck obstruction , bladder cancer , and/or pelvic irradiation , urinary incontinence , recurrent urinary tract infection , urethral stricture , bacterial prostatitis . History acute urinary retention ( ie , inability fully empty bladder ) . Had invasive urinary bladder procedure ( ie , cystoscopy ) within 7 day prior screen . Had phytotherapy within 2 week screen may need phytotherapy study . History low blood pressure ( orthostatic hypotension , hypotension [ supine blood pressure le 90/70 mm Hg ] ) , unstable angina , cardiovascular cerebral vascular event ( ie , transient ischemic attack [ TIA ] , stroke ) within previous 3 month prior enrollment , OR history dizziness , vertigo typical sign symptom low blood pressure . Recent history ( ie , within past year ) active addiction , abuse , misuse and/or dependence drug and/or alcohol . Use herbal therapy may impact study ( eg , Saw Palmetto ) within 2 week screen and/or predict need herbal therapy study . Individuals currently take herbal therapy may eligible study willing complete 2week washout period . Use finasteride drug similar action 12 month prior study screen . Individuals treat short period 5alpha reductase inhibitor ( 5ARIs ) drug antiandrogenic property within 12 month screen may eligible study . Use nonapproved ( investigational ) drug within last 4 week prior enrollment , current participation another clinical study . Allergic intolerant finasteride and/or tamsulosin .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>